Spirometer is a non-invasive medical device which is used to assess the functioning of lungs by measuring the amount of air inhaled and exhaled. Spirometer is a commonly used device for diagnosis of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and others. Spirometer may also be used to monitor the progress of a treatment for chronic lung disease in order to determine if a treatment is effective in helping the patient to breathe better. A spirometer is based on the measurement of two key factors: forced expiratory volume (FEV) and forced vital capacity (FVC). Forced expiratory volume can be defined as the air volume that can be forced out of the lungs in a second. Forced vital capacity is referred to as the largest volume of air that can be forced out of the lungs after a deep breath. FVC and FEV reading helps a physician to assess the severity of breathing problems faced by the patient. When the FVC reading is lower than the normal reading, it is indicative of restricted breathing while a lower FEV reading indicates severe obstruction in breathing.
Market Dynamics
The increasing prevalence of respiratory disorders, rising automation in the field of healthcare, and increasing adoption of inorganic growth strategies such as acquisitions, mergers, collaborations, and others by key players operating in the market, are the major factors that are expected to drive growth of the global spirometer market over the forecast period.
For instance, according to the statistics provided by the World Health Organization (WHO), in 2019 around 262 million people suffered from asthma globally, thus making asthma one of the major non-communicable disease which can affect both adults as well as children.
Key features of the study:
- This report provides in-depth analysis of the global spirometer market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global spirometer market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Koninklijke Philips N.V., SCHILLER, Midmark Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG, Guangzhou Medsinglong Medical Equipment Co., Ltd, and Welch Allyn
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global spirometer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spirometer market
Detailed Segmentation:
- Global Spirometer Market, By Product Type:
- Hand Held
- Table Top
- Desktop
- Global Spirometer Market, By Technology Type:
- Volume Measurement
- Flow Measurement
- Peak Flow Measurement
- Global Spirometer Market, By Application:
- Asthma
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Pulmonary Fibrosis
- Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)
- Global Spirometer Market, By End User:
- Hospitals and Clinics
- Home Healthcare
- Global Spirometer Market, By Region:
- North America
- By Product Type
- Hand Held
- Table Top
- Desktop
- By Technology Type
- Volume Measurement
- Flow Measurement
- Peak Flow Measurement
- By Application
- Asthma
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Pulmonary Fibrosis
- Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)
- By End User
- Hospitals and Clinics
- Home Healthcare
- By Country
- Latin America
- By Product Type
- Hand Held
- Table Top
- Desktop
- By Technology Type
- Volume Measurement
- Flow Measurement
- Peak Flow Measurement
- By Application
- Asthma
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Pulmonary Fibrosis
- Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)
- By End User
- Hospitals and Clinics
- Home Healthcare
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type
- Hand Held
- Table Top
- Desktop
- By Technology Type
- Volume Measurement
- Flow Measurement
- Peak Flow Measurement
- By Application
- Asthma
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Pulmonary Fibrosis
- Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)
- By End User
- Hospitals and Clinics
- Home Healthcare
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type
- Hand Held
- Table Top
- Desktop
- By Technology Type
- Volume Measurement
- Flow Measurement
- Peak Flow Measurement
- By Application
- Asthma
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Pulmonary Fibrosis
- Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)
- By End User
- Hospitals and Clinics
- Home Healthcare
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type
- Hand Held
- Table Top
- Desktop
- By Technology Type
- Volume Measurement
- Flow Measurement
- Peak Flow Measurement
- By Application
- Asthma
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Pulmonary Fibrosis
- Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)
- By End User
- Hospitals and Clinics
- Home Healthcare
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type
- Hand Held
- Table Top
- Desktop
- By Technology Type
- Volume Measurement
- Flow Measurement
- Peak Flow Measurement
- By Application
- Asthma
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Pulmonary Fibrosis
- Others (Others include Emphysema, Chronic Bronchitis, and Bronchiectasis)
- By End User
- Hospitals and Clinics
- Home Healthcare
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Koninklijke Philips N.V.*
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- SCHILLER
- Midmark Corporation
- Smiths Medical
- Vyaire Medical, Inc.
- SDI Diagnostics
- Nihon Kohden Corporation
- COSMED srl
- Fukuda Sangyo Co. Ltd.
- Medicare Systems
- MGC Diagnostics Corporation
- LabTech
- Vitalograph
- Futuremed
- Geratherm Medical AG
- Guangzhou Medsinglong Medical Equipment Co., Ltd
- Welch Allyn
“*” marked represents similar segmentation in other categories in the respective section.
